OptimizeRx (OPRX) Receivables Refunds: 2023-2025
Historic Receivables Refunds for OptimizeRx (OPRX) over the last 3 years, with Q3 2025 value amounting to $1.7 million.
- OptimizeRx's Receivables Refunds rose 262968.75% to $1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 million, marking a year-over-year increase of 262968.75%. This contributed to the annual value of $1.0 million for FY2023, which is N/A changed from last year.
- As of Q3 2025, OptimizeRx's Receivables Refunds stood at $1.7 million, which was up 262968.75% from $646000.0 recorded in Q2 2025.
- Over the past 5 years, OptimizeRx's Receivables Refunds peaked at $1.8 million during Q2 2024, and registered a low of $64000.0 during Q3 2024.
- Its 3-year average for Receivables Refunds is $926285.7, with a median of $1.0 million in 2023.
- Over the last 5 years, OptimizeRx's Receivables Refunds had its largest YoY gain of 262968.75% in 2025, and its largest YoY loss of 8909.27% in 2025.
- Over the past 3 years, OptimizeRx's Receivables Refunds (Quarter) stood at $1.0 million in 2023, then plummeted by 93.82% to $64000.0 in 2024, then surged by 2629.69% to $1.7 million in 2025.
- Its Receivables Refunds was $1.7 million in Q3 2025, compared to $646000.0 in Q2 2025 and $113000.0 in Q1 2025.